Stay updated on PHA-022121 Dose Study for Acute Angioedema Clinical Trial
Sign up to get notified when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.

Latest updates to the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdds a new revision entry (v3.6.5) to the study history and removes the previous v3.6.4 entry, reflecting an update to the revision metadata for the record.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe record history now shows a new revision entry, v3.6.4, replacing the previous v3.6.3 in the history. This reflects an update to the page's revision metadata for the study record.SummaryDifference0.1%

- Check45 days agoChange DetectedThe footer revision label now reads v3.6.3, replacing the previous v3.6.2.SummaryDifference0.1%

- Check52 days agoChange DetectedThe revision history now includes a new latest revision entry (v3.6.2) and drops an older one (v3.6.0), reflecting an update to the page's version tracking. This preserves the historical record without altering study details.SummaryDifference0.1%

- Check60 days agoChange DetectedThis version removes multiple major sections from the study record view, including Arms and Interventions, Conditions, Study Description, Recruitment Status, and Study Design, across several dates. The deletions reduce visibility of core trial details in the public record.SummaryDifference14%

- Check67 days agoChange DetectedThe record indicates the study is no longer recruiting participants, marking a halt in enrollment. A new revision entry (v3.6.0) has been added to the history, replacing the prior revision (v3.5.5).SummaryDifference0.2%

Stay in the know with updates to PHA-022121 Dose Study for Acute Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.